Optimal dosing of heparin for prophylactic anticoagulation in critically ill COVID-19 patients a systematic review and meta-analysis of randomized controlled trials

PURPOSE: The optimal amount of anticoagulation for critically ill COVID-19 patients is controversial. Therefore, we aimed to evaluate the efficacy and safety of escalated doses of anticoagulation in critically ill patients with severe COVID-19. MATERIALS AND METHODS: We conducted a systematic search...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonfim, Luana C.M.G., Guerini, Isadora S., Zambon, Marjorie G., Pires, Gabriela B., Silva, Amanda C.F., Gobatto, André L.N., Lopes, Marcela A., Brosnahan, Shari B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10211463/
https://www.ncbi.nlm.nih.gov/pubmed/37244209
http://dx.doi.org/10.1016/j.jcrc.2023.154344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10211463/
https://www.ncbi.nlm.nih.gov/pubmed/37244209
http://dx.doi.org/10.1016/j.jcrc.2023.154344

Ejemplares similares